Found: 42
Select item for more details and to access through your institution.
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. 785, doi. 10.1111/bjh.18297
- By:
- Publication type:
- Article
Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 5, p. 1004, doi. 10.1111/bjh.17423
- By:
- Publication type:
- Article
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 562, doi. 10.1002/ajh.27233
- By:
- Publication type:
- Article
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 712, doi. 10.1002/ajh.26870
- By:
- Publication type:
- Article
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E35, doi. 10.1002/ajh.26789
- By:
- Publication type:
- Article
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. E275, doi. 10.1002/ajh.26202
- By:
- Publication type:
- Article
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02444
- By:
- Publication type:
- Article
Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future.
- Published in:
- Stem Cells Translational Medicine, 2014, v. 3, n. 12, p. 1435, doi. 10.5966/sctm.2014-0151
- By:
- Publication type:
- Article
Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.582213
- By:
- Publication type:
- Article
The Development of a Myeloablative, Reduced-Toxicity, Conditioning Regimen for Cord Blood Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2014, v. 14, n. 1, p. e1, doi. 10.1016/j.clml.2013.08.006
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes.
- Published in:
- 2013
- By:
- Publication type:
- journal article
CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S446, doi. 10.1016/S2152-2650(21)01992-3
- By:
- Publication type:
- Article
Poster: CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S258, doi. 10.1016/S2152-2650(21)01627-X
- By:
- Publication type:
- Article
Improved Acute Graft-versus Host Disease (aGVHD) and Progression Free Survival with Post-Transplant Cyclophosphamide in AML/MDS Patients (pts) with Prior CTLA-4 or PD-1 Blockade.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S11, doi. 10.1016/j.clml.2017.09.038
- By:
- Publication type:
- Article
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Which Patients Should Undergo Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes, and When Should We Do It?
- Published in:
- 2015
- By:
- Publication type:
- journal article
Haploidentical transplants for patients with graft failure after the first allograft.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E267, doi. 10.1002/ajh.25917
- By:
- Publication type:
- Article
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1382, doi. 10.1002/ajh.25647
- By:
- Publication type:
- Article
Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 222, doi. 10.1002/ajh.24959
- By:
- Publication type:
- Article
Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 845, doi. 10.1002/ajh.24782
- By:
- Publication type:
- Article
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 331, doi. 10.1002/ajh.24632
- By:
- Publication type:
- Article
Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 11, p. 1065, doi. 10.1002/ajh.24140
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 4, p. 395, doi. 10.1002/ajh.23655
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case-control study.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 198, doi. 10.1002/ajh.23371
- By:
- Publication type:
- Article
Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3568, doi. 10.1002/cncr.30770
- By:
- Publication type:
- Article
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 18, p. 3318, doi. 10.1002/cncr.28219
- By:
- Publication type:
- Article
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 6, p. 798, doi. 10.1111/bjh.12210
- By:
- Publication type:
- Article
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 5, p. 1, doi. 10.1111/tid.13395
- By:
- Publication type:
- Article
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 1, p. n/a, doi. 10.1111/tid.12632
- By:
- Publication type:
- Article
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 1, p. 74, doi. 10.1159/000507012
- By:
- Publication type:
- Article
Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01229-z
- By:
- Publication type:
- Article
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 19, p. 3333, doi. 10.1002/cncr.35388
- By:
- Publication type:
- Article
Molecular disparity of HLA‐DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 8, p. 1205, doi. 10.1002/cncr.34671
- By:
- Publication type:
- Article
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cytokines, Endothelium, and Adhesive Molecules in Pathologic Thrombopoiesis.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2001, v. 7, n. 2, p. 126, doi. 10.1177/107602960100700209
- By:
- Publication type:
- Article
Acute Budd-Chiari Syndrome Associated with Activated Protein C Resistance During Intravenous Anticoagulant Treatment.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 1998, v. 4, n. 3, p. 220, doi. 10.1177/107602969800400315
- By:
- Publication type:
- Article